Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 16/20 | 0.64 |
| ▸ | CCKAR | P32238 | 10/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9529682 | 1.00 | CCKBR (0.64) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL24611857 | 1.00 | CCKBR (0.64) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| Bromide SCHEMBL8611955 | 0.99 | CCKBR (0.62) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL12214181 | 0.91 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL14456273 | 0.85 | CCKBR (0.60) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL15402466 | 0.84 | CCKBR (0.62) | CCKBRCCKAR | |
| SCHEMBL10196569 | 0.84 | CCKBR (0.69) | CCKBRCCKAR | |
| SCHEMBL641936 | 0.84 | CCKBR (0.59) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL642974 | 0.84 | CCKBR (0.72) | CCKBRCCKAR | |
| SCHEMBL29766969 | 0.84 | CCKBR (0.72) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3324977-B1 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | ENANTA PHARM INC (US) | 2022-07-13 | — | — | EP | disclosed |
| EP-3582784-B1 | PROCESSES FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES | ENANTA PHARM INC (US) | 2022-06-08 | — | — | EP | disclosed |
| EP-3497096-B1 | AN ANTIMICROBIAL COMPOUND | THE UNIV OF DURHAM (GB) | 2021-11-10 | — | — | EP | disclosed |
| WO-2019067864-A1 | COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2019-04-04 | — | — | WO | disclosed |
| WO-2018033714-A1 | AN ANTIMICROBIAL COMPOUND | THE UNIVERSITY OF DURHAM (GB) | 2018-02-22 | — | — | WO | disclosed |
| US-7390801-B2 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds | ATHENA NEUROSCIENCES, INC. (US) | 2008-06-24 | — | — | US | disclosed |
| EP-0167919-B1 | BENZODIAZEPINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MERCK & CO. INC. (US) | 1993-05-05 | — | — | EP | disclosed |
| US-5004741-A | Cholecystokinin(CCK); Treating Disorders Of The Gastrointestinal Tract, Central Nervous System And Of The Appetite Of Animals | MERCK & CO., INC. (US) | 1991-04-02 | — | — | US | disclosed |
| US-4820834-A | Benzodiazepine analogs | MERCK & CO., INC. (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0284256-A1 | Benzodiazepine analogs | MERCK & CO. INC. (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0167919-A2 | Benzodiazepine derivatives and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-01-15 | — | — | EP | disclosed |